Answer
Yes, IVIg may contain neutralising antibodies that inactivate imlifidase when given beforehand; its 3–4-week half-life should be considered, and clinical studies excluded IVIg administration within 4 weeks before imlifidase infusion.
Sources for this answer
- Idefirix 11 mg powder for concentrate for solution for infusionHansa Biopharma AB · emc · SmPC §4.5 Interaction with other medicinal products · Version 8Document updated
Sources checked